ADAIR

Vallon's abuse-resistant Adderall fails clinical trial, causing stock to crater
Fierce Biotech
Tue, 03/22/22 - 10:11 am
Vallon Pharmaceuticals
ADAIR
Adderall
ADHD
clinical trials